Remibrutinib in Real-world Clinical Practice

Clinical trial NCT07358364 · RECRUITING

Trial details

NCT number: NCT07358364
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Spontaneous Urticaria

Start date: 2026-02-02
Primary completion: 2031-10-30
Enrollment: 3280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.